As HCQ has been proven to be an effective drug in the NCF1 p.R90H–aggravated lupus mouse model, we proceed to investigate the effect of HCQ on in vitro PBMCs from patients with different genotypes. This evidence concerns the gene NCF1 and systemic lupus erythematosus.